Is immunosuppressive and thrombolytic therapy really effective in a patient with intracardiac thrombosis and pulmonary artery aneurysm due to Behçet’s disease?

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Behçet’s disease (BD) is a rare, multisystemic, chronic vasculitic disorder with unknown etiology. Intracardiac thrombus formation and pulmonary artery aneurysm in BD are very rare. The treatment protocol in patients with vascular involvement, particularly those with pulmonary artery aneurysm accompanied by thrombosis, have not been clearly defined. In this article, we report an exceptional case, who had been treated unsuccessfully with a combination of anti-inflammatory/immunosuppressive therapy and thrombolytic agents, to discuss the poor prognosis of pulmonary artery aneurysm accompanying intracardiac thrombosis in juvenile BD.

Cite

CITATION STYLE

APA

Aladağ Çiftdemir, N., Gökalp, S., & Eren, T. (2019). Is immunosuppressive and thrombolytic therapy really effective in a patient with intracardiac thrombosis and pulmonary artery aneurysm due to Behçet’s disease? Archives of Rheumatology, 34(4), 451–456. https://doi.org/10.5606/ArchRheumatol.2019.7169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free